Literature DB >> 30921261

Hepatic Venous Pressure Gradient Measurements in Children: Correlation With Hepatic Histology and Clinical Indicators of Portal Hypertension.

Noelle H Ebel1, Kristen Carlin2, Michele L Shaffer3, Giri Shivaram4, Matthew Hawkins5, Erin R Lane6, Kara Cooper2, Will S Lindquester7, Gaurav Gadodia8, Karen F Murray2,6.   

Abstract

OBJECTIVES: In adults, elevated hepatic venous pressure gradients (HVPGs) are correlated with the degree of liver fibrosis on histopathology and predict worse outcomes including variceal bleeding and death. We aimed to examine the association between HVPG measurements, histopathologic findings, and clinical indicators of portal hypertension in children.
METHODS: Utilizing retrospective data from 2 pediatric centers between 2006 and 2015, we identified children who underwent simultaneous HVPG measurement and transjugular liver biopsy. Medical charts were reviewed for histopathology, imaging, endoscopic, and clinical data.
RESULTS: Forty-one children (median age 11 years) were included in the analysis with diagnoses of acute hepatitis (n = 15), chronic liver disease (n = 12), hepatic noncirrhotic portal hypertension (n = 4), acute liver failure (n = 3), and nonhepatic causes of portal hypertension (n = 7). Elevated mean HVPG measurements were found in children with acute liver failure (10 mmHg, range 4-12) and chronic liver disease (7 mmHg, range 1-12). HVPG measurements did not correlate with the histological severity of fibrosis (ρ = 0.23, P = 0.14) or portal inflammation (ρ = 0.24, P = 0.29), and no difference was found in HVPG when comparing children with and without a history of variceal bleeding (P = 0.43).
CONCLUSIONS: HVPG measurements do not correlate significantly with the degree of hepatic fibrosis on biopsy. Furthermore, HVPG measurements are not associated with the presence of varices or history of variceal bleeding, suggesting the possibility of intrahepatic shunting in children with advanced liver disease. Therefore, unlike in adults, HVPG measurements may not accurately predict children who are at risk of complications from portal hypertension.

Entities:  

Year:  2019        PMID: 30921261      PMCID: PMC6534464          DOI: 10.1097/MPG.0000000000002327

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  16 in total

1.  Updating consensus in portal hypertension: report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension.

Authors:  R de Franchis
Journal:  J Hepatol       Date:  2000-11       Impact factor: 25.083

Review 2.  The hepatic venous pressure gradient: anything worth doing should be done right.

Authors:  Roberto J Groszmann; Suchat Wongcharatrawee
Journal:  Hepatology       Date:  2004-02       Impact factor: 17.425

Review 3.  Assessing portal hypertension in liver diseases.

Authors:  Annalisa Berzigotti; Susana Seijo; Enric Reverter; Jaime Bosch
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2013-02       Impact factor: 3.869

4.  Histological-hemodynamic correlation in cirrhosis-a histological classification of the severity of cirrhosis.

Authors:  Satish Nagula; Dhanpat Jain; Roberto J Groszmann; Guadalupe Garcia-Tsao
Journal:  J Hepatol       Date:  2005-09-23       Impact factor: 25.083

5.  Quantitative histological-hemodynamic correlations in cirrhosis.

Authors:  Supatsri Sethasine; Dhanpat Jain; Roberto J Groszmann; Guadalupe Garcia-Tsao
Journal:  Hepatology       Date:  2012-04       Impact factor: 17.425

6.  Measurement of hepatic vein pressure gradient in children with chronic liver diseases.

Authors:  Roberto Miraglia; Angelo Luca; Luigi Maruzzelli; Marco Spada; Silvia Riva; Settimo Caruso; Giuseppe Maggiore; Bruno Gridelli; Jaime Bosch
Journal:  J Hepatol       Date:  2010-06-16       Impact factor: 25.083

Review 7.  Primary prophylaxis of variceal hemorrhage in children with portal hypertension: a framework for future research.

Authors:  Simon C Ling; Thomas Walters; Patrick J McKiernan; Kathleen B Schwarz; Guadalupe Garcia-Tsao; Benjamin L Shneider
Journal:  J Pediatr Gastroenterol Nutr       Date:  2011-03       Impact factor: 2.839

Review 8.  Now there are many (stages) where before there was one: In search of a pathophysiological classification of cirrhosis.

Authors:  Guadalupe Garcia-Tsao; Scott Friedman; John Iredale; Massimo Pinzani
Journal:  Hepatology       Date:  2010-04       Impact factor: 17.425

9.  Cardiac hepatopathy: clinical, hemodynamic, and histologic characteristics and correlations.

Authors:  Robert P Myers; Raimondo Cerini; Raymond Sayegh; Richard Moreau; Claude Degott; Didier Lebrec; Samuel S Lee
Journal:  Hepatology       Date:  2003-02       Impact factor: 17.425

Review 10.  The clinical use of HVPG measurements in chronic liver disease.

Authors:  Jaime Bosch; Juan G Abraldes; Annalisa Berzigotti; Juan Carlos García-Pagan
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-09-01       Impact factor: 46.802

View more
  6 in total

1.  Diffusion tensor imaging of the spleen in prediction and grading of esophageal varices in cirrhotic children with portal hypertension.

Authors:  Ahmed Abdel Khalek Abdel Razek; Mona Mohamed Hafez; Walaa Mahmoud; Ahmed Ramadan Ismail; Khadiga M Ali; Tarek Elsayed Barakat
Journal:  Jpn J Radiol       Date:  2021-04-29       Impact factor: 2.374

2.  Band ligation versus sham or no intervention for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis.

Authors:  Lorena I Cifuentes; Daniela Gattini; Romina Torres-Robles; Juan Cristóbal Gana
Journal:  Cochrane Database Syst Rev       Date:  2021-01-26

3.  Beta-blockers versus placebo or no intervention for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis.

Authors:  Lorena I Cifuentes; Daniela Gattini; Romina Torres-Robles; Juan Cristóbal Gana
Journal:  Cochrane Database Syst Rev       Date:  2021-01-26

4.  Sclerotherapy versus beta-blockers for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis.

Authors:  Daniela Gattini; Lorena I Cifuentes; Romina Torres-Robles; Juan Cristóbal Gana
Journal:  Cochrane Database Syst Rev       Date:  2020-01-10

5.  Band ligation versus sclerotherapy for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis.

Authors:  Juan Cristóbal Gana; Lorena I Cifuentes; Daniela Gattini; Romina Torres-Robles
Journal:  Cochrane Database Syst Rev       Date:  2020-11-06

6.  Sclerotherapy versus sham or no intervention for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis.

Authors:  Daniela Gattini; Lorena I Cifuentes; Romina Torres-Robles; Juan Cristóbal Gana
Journal:  Cochrane Database Syst Rev       Date:  2020-03-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.